LGP, MGC Pharma fined for alleged unlawful advertising of medicinal cannabis products
Two listed medicinal cannabis companies have been hit with 51 infringement notices over the alleged unlawful advertising of products online, leading to cumulative fines totalling $679,920.
Of the two companies, Little Green Pharma (ASX: LGP) was slugged with the heaviest penalty of $372,960 stemming from 28 infringement notices, while MGC Pharmaceuticals (ASX: MXC) has been ordered to pay $306,960 in relation to 23 notices from the Therapeutic Goods Administration (TGA).
In an ASX statement, LGP says the fines relate to the promotion of its medicinal cannabis products online and on certain social media channels, which the watchdog alleges breaches the TGA Act.
Comments
Post a Comment